OTCMKTS:KAYS Kaya (KAYS) Stock Price, News & Analysis → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free KAYS Stock Alerts $0.04 0.00 (0.00%) (As of 05/23/2024 ET) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.03▼$0.0552-Week Range$0.03▼$0.09Volume169 shsAverage Volume7,879 shsMarket Capitalization$556,416.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Kaya alerts: Email Address Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. About Kaya Stock (OTCMKTS:KAYS)Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States. It offers a range of cannabis products, including flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. The company also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, it is involved in the development of a psychedelic treatment center under The Sacred Mushroom name, that provides its guests access to psilocybin treatments, located in Portland, Oregon. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. is headquartered in Fort Lauderdale, Florida.Read More KAYS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KAYS Stock News HeadlinesMay 23 at 1:29 PM | msn.comEmily Burns Releases New Single ‘8 Hours Behind’May 20 at 8:49 AM | msn.comDineo Ranaka ruffles feathers after slamming radio industry, calls out male dominanceMay 19, 2024 | msn.comGymnastics-Team Japan in Paris will be strongest ever, says medallist KayaMay 16, 2024 | investorplace.comKAYS Stock Earnings: Kaya Holdings Reported Results for Q1 2024May 16, 2024 | msn.comSizwe Dhlomo was out and about and showed off his shooting skillsMay 16, 2024 | msn.comHow ‘The Gentlemen' casting director Dan Hubbard knew Theo James and Kaya Scodelario would have chemistry [Exclusive Video Interview]May 16, 2024 | msn.comMarcos says Bamban Mayor Guo must be investigated: ‘Nobody knows her’May 14, 2024 | msn.comKaya Scodelario: 'It's very easy to be written off as difficult to work with as a woman'May 10, 2024 | msn.comKaya Scodelario & Billie Lourd Join Alex Winter’s Noir ‘Adulthood’May 10, 2024 | msn.comKaya Scodelario lands next movie role following The Gentlemen successMay 10, 2024 | msn.comKaya Scodelario & Billie Lourd Join Alex Winter's Noir ‘Adulthood'May 10, 2024 | msn.comMarcos: Joint military exercises can help ensure stability in WPSMay 10, 2024 | msn.comElsbeth Recap: Death By Corporate-speakMay 9, 2024 | msn.comPot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In OregonMay 6, 2024 | msn.comVIDEO: Unathi Nkayi opens up about losing contracts post-Kaya FM exitMay 6, 2024 | msn.comThe Cast Of Netflix's 'The Gentlemen,' Ranked By Net WorthMay 5, 2024 | msn.comKwale Kaya elders embark on restoring degraded Kaya Tiwi forestMay 4, 2024 | msn.comCFC squares off with Kaya Iloilo on SundayMay 3, 2024 | msn.comOwner Convinced Cat and Dog Are in Love Asks: 'Is This Normal?'May 2, 2024 | msn.comPVL: Choco Mucho boosts Finals bid with sweep of Chery TiggoMay 1, 2024 | nj.comHow to watch ‘Dance Moms: Epic Showdowns’ Premiere (for free)April 30, 2024 | msn.comHayden Panettiere Gives Rare Update on Daughter Kaya Who Lives With Her Dad in UkraineApril 29, 2024 | msn.com‘It’s a very abusive industry’: Dineo Ranaka on how radio makes her sickApril 29, 2024 | msn.comDineo Ranaka opens up about how radio makes her sickApril 29, 2024 | msn.comMarcos to farmers: Take care of people-owned agri infrastructureSee More Headlines Receive KAYS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kaya and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today5/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Discretionary Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:KAYS CUSIPN/A CIK1530746 Webwww.kayaholdings.com Phone(954) 892-6911FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.61 million Net Margins260.23% Pretax Margin292.95% Return on Equity-2.75% Return on Assets196.57% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual Sales$200,000.00 Price / Sales2.94 Cash Flow$0.13 per share Price / Cash Flow0.32 Book Value($1.14) per share Price / Book-0.04Miscellaneous Outstanding Shares14,720,000Free Float11,260,000Market Cap$588,800.00 OptionableNot Optionable Beta0.54 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Craig R. Frank (Age 64)Chairman, President, CEO & Acting CFO Comp: $300kMr. Bryan ArnoldVice President of MarketingChad CraigSenior Vice President of Oregon OperationsKey CompetitorsKayaOTCMKTS:KAYSDChina SXT PharmaceuticalsNASDAQ:SXTCPainReformNASDAQ:PRFXNovaBay PharmaceuticalsNYSEAMERICAN:NBYArgos TherapeuticsOTCMKTS:ARGSQView All Competitors KAYS Stock Analysis - Frequently Asked Questions How have KAYS shares performed in 2024? Kaya's stock was trading at $0.0421 on January 1st, 2024. Since then, KAYS stock has decreased by 10.2% and is now trading at $0.0378. View the best growth stocks for 2024 here. How were Kaya's earnings last quarter? Kaya Holdings, Inc. (OTCMKTS:KAYS) issued its quarterly earnings results on Tuesday, April, 16th. The company reported $0.01 EPS for the quarter. The firm earned $0.03 million during the quarter. Kaya had a negative trailing twelve-month return on equity of 2.75% and a net margin of 260.23%. What other stocks do shareholders of Kaya own? Based on aggregate information from My MarketBeat watchlists, some companies that other Kaya investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), iAnthus Capital (ITHUF), Unrivaled Brands (TRTC), CymaBay Therapeutics (CBAY), Cronos Group (CRON), BOTS (MCIG), Medical Marijuana (MJNA) and How do I buy shares of Kaya? Shares of KAYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:KAYS) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe Presidential candidate you should REALLY be worried aboutStansberry ResearchWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsNew Options need New Trading StrategiesNetpicksExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaya Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.